CRIZALK 250MG CAPSULE
Introduction:
Crizalk 250mg
Capsules contain the active ingredient crizotinib. It is prescribed to treat
patients who have been diagnosed with a lung cancer called non-small cell lung
cancer (NSCLC). This drug is active against altered forms of the ALK protein
when the patient does not respond to other anticancer treatments.
Tell your doctor about any symptoms such as yellowing of the
skin, dark urine, nausea, vomiting, loss of appetite, pain in the right side of
the abdomen, bleeding and bruising.
Uses of Crizalk 250mg Capsule:
Treatment of advanced lung cancer (NSCLC) that has spread to
other organs.
How Crizalk 250mg
Capsule works: Mutations or changes in the ALK protein play an essential role
in the progression of tumor cells. ALK-positive refers to cancer cells that
contain errors in the gene responsible for making the ALK enzyme. Crizalk 250mg
Capsule inhibits the anaplastic lymphoma kinase (ALK) enzyme and stops the
tumor growth.
Interactions with
other drugs:
Before treatment, tell your doctor about all medicines you
are taking or are taking.
More information:
Store at room temperature (15-30˚C) in the original
container.
For other medicines and pharmaceutical help checkout MrMed.
Comments
Post a Comment